A randomised, controlled trial comparing the immunogenecity and safety of a 23âvalent pneumococcal polysaccharide vaccination to a repeated dose 13âvalent pneumococcal conjugate vaccination in kidney transplant recipients
Eriksson, Mari, Käyhty, Helena, Saha, Heikki, Lahdenkari, Mika, Koskinen, Petri, Mäkisalo, Heikki, Anttila, VeliâJukkaJournal:
Transplant Infectious Disease
DOI:
10.1111/tid.13343
Date:
May, 2020
File:
PDF, 1.77 MB
2020